Compounds having the formula I wherein R1, R2, R3, R4, and R5 are as defined herein are Hepatitis C virus NS5b polymerase inhibitors. Also disclosed are compositions and methods for treating an HCV infection and inhibiting HCV replication.
申请公布号
BR112012005616(A2)
申请公布日期
2016.06.21
申请号
BR20121105616
申请日期
2010.09.17
申请人
F. HOFFMANN-LA ROCHE AG
发明人
FRANCISCO XAVIER TALAMAS;JAVIER DE VICENTE FIDALGO;JIM LI;RYAN CRAIG SCHOENFELD
